-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Enovix, Lowers Price Target to $21

Benzinga·05/14/2026 17:44:46
Listen to the news
Oppenheimer analyst Colin Rusch maintains Enovix (NASDAQ:ENVX) with a Outperform and lowers the price target from $24 to $21.